I think next catalyst will be MSB receiving formal minutes of their March FDA meeting this month and then MSB announcing on the ASX on the exact next steps in the progression of the Adult aGVHD trial and agreeance of their potency assay approach for the trial!
Double confirmation on MSB’s potency assay newly minted patent and approach.
Bam…lock in the the FDA to MSB’s potency assay methodology!
Upcoming Newsflow & Re-rate Estimations, page-7
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.5¢ |
Change
-0.025(2.58%) |
Mkt cap ! $1.078B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 94.0¢ | $2.482M | 2.602M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 71720 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 10463 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |